A Case Series of Lung Sequelae and
Aspergillus Antigenemia: A Hidden Entity
in Post-COVID-19 Critically ill Patients
Published: May 1, 2021 | DOI: https://doi.org/10.7860/JCDR/2021/48272.14902
Sonali Banwait, Poonam Gupta
1. Associate Professor, Department of Anaesthesia and Critical Care, VMMC and Safdarjung Hospital, New Delhi, India.
2. Consultant and Professor, Department of Anaesthesia and Critical Care, VMMC and Safdarjung Hospital, New Delhi, India.
Correspondence
Dr. Sonali Banwait,
A-701, Delhi State Society, Plot No. 1, Sector-19, Dwarka, New Delhi, India.
E-mail: sonalibanwait@gmail.com
Coronavirus Disease-2019 Associated Invasive Aspergillosis (CAPA) is a known entity with significant mortality. There is paucity of literature with secondary aspergillosis infection in post-COVID-19 patients. Serum galactomannan is a highly sensitive test for screening patients for Aspergillus antigenemia. Here, authors reported five post-COVID-19 patients with High Resolution Computed Tomography (HRCT) features and associated high risk factors for opportunistic aspergillosis (55-years-old-male, 46-years-old-male, 75-years-old-female, 55-years-old-female and 27-years-old-male) like prolonged intensive care stay, Acute Respiratory Distress Syndrome (ARDS), corticosteroid and broad spectrum antibiotic therapy like Meropenem, Colistin and Targocid etc.
[
FULL TEXT ] | [ PDF]